COVID-19 has resulted in more than 120 million cases and 2.6 million deaths to date. Respiratory and gastrointestinal symptoms are accompanied by short- and long-term neuropsychiatric symptoms (NPs) and long-term brain sequelae. Some patients present with anosmia, cognitive and attention deficits (ie, brain fog), new-onset anxiety, depression, psychosis, seizures, and even suicidal behavior. These present […]
How COVID-19 Affects the Brain Read More »
The current pandemic of Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has undergone an observed exponential increase of cases that has overrun hospitals across the world. Many people have mild forms of the disease and are advised not to go to the hospital or to seek a diagnostic test
Modeling the Onset of Symptoms of COVID-19 Read More »
Studies by the signatories and other scientists have demonstrated beyond any reasonable doubt that viruses are released during exhalation, talking, and coughing in microdroplets small enough to remain aloft in air and pose a risk of exposure at distances beyond 1–2 m from an infected individual. For example, at typical indoor air velocities, a 5-μm
It is Time to Address Airborne Transmission of COVID-19 Read More »
“This is the training program no business can be without, not only during this pandemic, but long after. Prevention, health and safety, leadership, employee morale, customer relations – it’s all here.” Ambassador [ret.] Dr. Neil Parsan
PANDEMIC PREPAREDNESS: COVID-19 ONLINE TRAINING Read More »
The risk of contracting coronavirus disease 2019 (COVID-19) during air travel is lower than from an office building, classroom, supermarket, or commuter train. Modern airplanes maintain clean air by circulating a mix of fresh air and air recycled through HEPA filters, the same type of air filters used in hospital operating rooms.
Risk of COVID-19 During Air Travel Read More »
It’s not just the mask, it’s the humidity created inside the mask that helps protect against severe COVID-19, a recent study by National Institutes of Health (NIH) researchers suggests. The use of cloth masks has been linked with decreased disease severity, which is sur- prising considering such masks aren’t good at filtering out the smallest
Another Explanation for Why Cloth Masks Reduce COVID-19 Severity Read More »
On December 11, 2020, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine, administered as 2 doses separated by 21 days. Shortly after, the Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation for its use. Following implementation of vaccination, reports of
As COVID-19 cases resulting from infection with SARS-CoV-2 variants accumulate in the US and around the world, one question looms large: How well do the COVID-19 vaccines developed so far protect against these novel coronavirus spinoffs?
COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough Read More »
Since the COVID-19 pandemic began on March 11, 2020, there has been concern that survivors might be at an increased risk of neurological disorders. This concern, initially based on findings from other coronaviruses, was followed rapidly by case series, emerging evidence of COVID-19 CNS involvement, and the identification of mechanisms by which this could occur. Similar concerns have been
A year into the coronavirus disease 2019 (COVID-19) pandemic there remains an urgent need to limit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread and to curb the pandemic in the US through nonpharmaceutical interventions. Clear evidence supports the effectiveness of simple strategies in identifying risks and mitigating the spread of infection, with much of
Identifying COVID-19 Risk Through Observational Studies to Inform Control Measures Read More »
